ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Amazon, Apple Lead a Packed Earnings Week

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Today brings a double shot from the S&P 500. AMZN and INTC both report Q3 results after the close. GILD and ILMN also release today. BMY and EMCOR hold calls this morning.

In Europe, Renault posts its sales statement today. ORTEX alt data tracking Austrian car registrations shows Renault running +6% on the same quarter last year, with all three months logged. Dutch car registrations, another leading indicator for the French automaker, are running -19% year-on-year. The two signals pull in opposite directions ahead of the print.

Volkswagen, also reporting today, faces a gloomier read. Austrian car registrations, which lead its revenue by 18 days, are running -6% on the same quarter last year.

Monday brings AAPL Q4 results. The iPhone maker's fiscal year ends in September. Markets will focus on iPhone 17 sales and any commentary on tariff exposure.

AMGN and BKNG report Monday. APO and AME hold calls. RACE reports next Tuesday. Austrian registrations point -75% year-on-year for the quarter, though the fit between that dataset and Ferrari revenue is noted as weak.

No IPOs are scheduled in the next seven days.

On the index front, the Russell 2000 December review cuts off tomorrow. ORTEX Index Rebalance Radar shows 102 names still undecided, with about 14 expected to be cut. Twist Bioscience's deletion odds jumped overnight from 20% to 55%, with $1.4B of forced tracker selling at stake if it holds below the exit line.

Stocks in this article

How this article was generated

Generated
29 Oct 2026, 00:31
Prompt version
v1.0
Data sources
EarningsAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.